UBS Group

UBS Group Portfolio holdings

AUM $478B
1-Year Return 17.78%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Quarter Return
-10.85%
1 Year Return
+17.78%
3 Year Return
+59.77%
5 Year Return
+91.78%
10 Year Return
+181.19%
AUM
$195B
AUM Growth
-$38.9B
Cap. Flow
-$3.57B
Cap. Flow %
-1.83%
Top 10 Hldgs %
15.35%
Holding
10,575
New
1,073
Increased
3,313
Reduced
4,704
Closed
843

Sector Composition

1 Technology 14.59%
2 Healthcare 8.77%
3 Financials 8.68%
4 Consumer Discretionary 6.48%
5 Industrials 5.77%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IXSE
6426
DELISTED
WisdomTree India Ex-State-Owned Enterprises Fund
IXSE
$14K ﹤0.01%
461
+420
+1,024% +$12.8K
UTAA
6427
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$14K ﹤0.01%
+1,382
New +$14K
AFLG icon
6428
First Trust Active Factor Large Cap ETF
AFLG
$412M
$14K ﹤0.01%
+627
New +$14K
CPTK.U
6429
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
$14K ﹤0.01%
1,406
AVTA
6430
DELISTED
Avantax, Inc. Common Stock
AVTA
$14K ﹤0.01%
765
-6,879
-90% -$126K
PRPC.U
6431
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$14K ﹤0.01%
1,403
-9,289
-87% -$92.7K
ARTE
6432
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
$14K ﹤0.01%
1,364
-104
-7% -$1.07K
OPNT
6433
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$14K ﹤0.01%
1,180
+158
+15% +$1.88K
IRL
6434
DELISTED
NEW IRELAND FUND INC
IRL
$14K ﹤0.01%
1,737
+275
+19% +$2.22K
FTAAU
6435
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$14K ﹤0.01%
1,449
+29
+2% +$280
EPHYU
6436
DELISTED
Epiphany Technology Acquisition Corp. Unit
EPHYU
$14K ﹤0.01%
1,376
-1,123
-45% -$11.4K
AVEO
6437
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$14K ﹤0.01%
2,161
-3,293
-60% -$21.3K
NGC.U
6438
DELISTED
Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant
NGC.U
$13K ﹤0.01%
1,377
+24
+2% +$227
WPCB
6439
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$13K ﹤0.01%
+1,370
New +$13K
CYRN
6440
DELISTED
CYREN Ltd.
CYRN
$13K ﹤0.01%
6,574
+6,110
+1,317% +$12.1K
CHAD
6441
DELISTED
Direxion Daily CSI 300 China A Share Bear 1X Shares
CHAD
$13K ﹤0.01%
752
-235
-24% -$4.06K
ITQRU
6442
DELISTED
Itiquira Acquisition Corp. Unit
ITQRU
$13K ﹤0.01%
1,291
-200
-13% -$2.01K
GRU
6443
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Grains Total Return
GRU
$13K ﹤0.01%
+2,512
New +$13K
PRBM.U
6444
DELISTED
Parabellum Acquisition Corp. Units, each consisting of one share of Class A common stock and three-quarters of one redeemable warrant
PRBM.U
$13K ﹤0.01%
1,302
+83
+7% +$829
NAACU
6445
DELISTED
North Atlantic Acquisition Corporation Unit
NAACU
$13K ﹤0.01%
1,336
-4,244
-76% -$41.3K
PQIN
6446
DELISTED
PGIM Quant Solutions Strategic Alpha International Equity ETF
PQIN
$13K ﹤0.01%
272
-14
-5% -$669
ALGM icon
6447
Allegro MicroSystems
ALGM
$5.82B
$13K ﹤0.01%
626
-13,751
-96% -$286K
ANGO icon
6448
AngioDynamics
ANGO
$438M
$13K ﹤0.01%
656
-10,228
-94% -$203K
ASRT icon
6449
Assertio
ASRT
$87M
$13K ﹤0.01%
4,639
+3,988
+613% +$11.2K
TRVI icon
6450
Trevi Therapeutics
TRVI
$992M
$13K ﹤0.01%
4,771
+3,147
+194% +$8.58K